Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Humira in Psoriasis and Vascular Inflammation (VIP-E)
NCT01866592Phase 4Completed
- Sponsor
- University of Pennsylvania
- Start
- Apr 2013
- Primary completion
- Aug 2016
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of adalimumab in psoriasis, cardiovascular disease (CVD), sponsored by University of Pennsylvania. Started Apr 2013; status: completed.
02
Drugs
03
Conditions
psoriasiscardiovascular disease (CVD)
Beyond the preview
Go deeper on NCT01866592.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01866592.